Meeting
2017 Cancer Survivorship Symposium
Long-term side effects of high-risk neuroblastoma survivors in a referral center in central Illinois.
Authors
Beth Speckhart
Children's Hospital of Illinois, Peoria, IL
Beth Speckhart , Reuben Antony , Karen S. Fernandez
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Late- and Long-term Effects/Comorbidities, Psychosocial Issues, and Recurrence and Secondary Malignancies
Track
Late- and Long-term Effects/Comorbidities,Psychosocial Issues,Recurrence and Secondary Malignancies
Sub Track
Long-term Complications/Sequelae of Treatment (Noncancer)
Citation
J Clin Oncol 35, 2017 (suppl 5S; abstr 129)
DOI
10.1200/JCO.2017.35.5_suppl.129
Abstract #
129
Poster Bd #
D5
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Breakthrough
Validating process mining in pediatric oncology: Demonstrating protocol adherence and variability in neuroblastoma treatment.
First Author: Astrid van Barneveld
Poster
2024 ASCO Genitourinary Cancers Symposium
Longitudinal assessment of cognitive functioning in testicular germ cell tumor survivors.
First Author: Zuzana Orszaghova
Poster
2023 ASCO Quality Care Symposium
Impact of survivorship care plans on mortality in a contemporary cohort of childhood cancer survivors.
First Author: Sharon M. Castellino
Poster
2023 ASCO Annual Meeting
Evaluation of palbociclib in combination with topotecan and cyclophosphamide in pediatric patients with recurrent or refractory neuroblastoma.
First Author: Theodore Willis Laetsch